日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants

针对祖先毒株(ERAGEM)、Delta 和 Omicron 变异株的灭活二价 SARS-CoV-2 疫苗的有效性

Kaplan, Busra; Pavel, Shaikh Terkis Islam; Uygut, Muhammet Ali; Tunc, Merve; Eroksuz, Yesari; Celik, Ilhami; Eren, Esma Eryilmaz; Korukluoglu, Gulay; Kara, Ates; Ozdarendeli, Aykut; Yetiskin, Hazel

Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months.

接种灭活 SARS-CoV-2 疫苗 TURKOVAC 可诱导长达 8 个月的持久体液和细胞免疫反应

Yılmaz Seçil, Eken Ahmet, Sezer Zafer, Bağcı Burcu Şen, Erdem Serife, Sarıkaya Medine Doğan, Kaplan Busra, Inal Ahmet, Bayram Adnan, Kalın Unuvar Gamze, Zararsız Gokmen, Yerlitas Serra İlayda, Cakir Nuri, Pavel Shaikh Terkis Islam, Uygut Muhammet Ali, Yetiskin Hazel, Kara Ates, Ozdarendeli Aykut

Effect of Limosilactobacillus reuteri DSM17938 to prevent antibiotic-associated diarrhea in children: prospective, multi-center, randomized, placebo-controlled clinical trial (PEARL Study)

罗伊氏乳杆菌DSM17938预防儿童抗生素相关性腹泻的效果:前瞻性、多中心、随机、安慰剂对照临床试验(PEARL研究)

Dinleyici, Ener Cagri; Ozen, Metehan; Guven, Sirin; Dalgic, Nazan; Karbuz, Adem; Sutcu, Murat; Turel, Ozden; Oz, Fatma Nur; Kirli, Ulviye; Yasar Durmus, Sevgi; Yazar, Ahmet Sami; Cakin, Zeynep Ebru; Vandenplas, Yvan; Kara, Ates

The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccines

既往SARS-CoV-2感染对接种TURKOVAC或CoronaVac灭活COVID-19疫苗个体接种后不良事件的影响

Durusu Tanriover, Mine; Altuntas Aydin, Ozlem; Guner, Rahmet; Yildiz, Orhan; Celik, Ilhami; Kose, Sukran; Akhan, Sila; Akalin, Emin Halis; Ozdarendeli, Aykut; Unal, Serhat; Ates, Ihsan; Kara, Ates

Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up

TURKOVAC同源第三剂加强免疫疫苗的长期免疫原性和安全性:2期临床研究结果及加强免疫后32周随访

Sezer, Zafer; Pavel, Shaikh Terkis Islam; Inal, Ahmet; Yetiskin, Hazel; Kaplan, Busra; Uygut, Muhammet Ali; Aslan, Ahmet Furkan; Bayram, Adnan; Mazicioglu, Mumtaz; Kalin Unuvar, Gamze; Yuce, Zeynep Ture; Aydin, Gunsu; Kaya, Refika Kamuran; Ates, Ihsan; Kara, Ates; Ozdarendeli, Aykut

Pathogens in Pediatric Septic Arthritis: A Multi-Center Study in Turkiye (PEDSART Study)

儿童化脓性关节炎病原体:土耳其多中心研究(PEDSART 研究)

Iseri Nepesov, Merve; Kilic, Omer; Sali, Enes; Yesil, Edanur; Akar, Asuman; Kaman, Ayse; Metin Akcan, Ozge; Kilic Cil, Merve; Ozlu, Canan; Lacinel Gurlevik, Sibel; Ulusoy, Emel; Cetin, Benhur Sirvan; Akici, Narin; Cakir, Deniz; Uslu Aygun, Fatma Deniz; Hancerli, Cafer Ozgur; Tekin Yilmaz, Ayse; Alkan, Gulsum; Uygun, Hatice; Bucak, Ibrahim Hakan; Bursal, Burcu; Celik, Taylan; Sutcu, Murat; Oz, Fatma Nur; Gayretli Aydin, Zeynep Gokce; Karbuz, Adem; Akturk, Hacer; Kepenekli, Eda; Emiroglu, Melike; Oncel, Selim; Nuhoglu, Cagatay; Korucu, Ismail Hakki; Incesu, Mustafa; Kaya, Ahmet; Bombaci, Hasan; Dinleyici, Meltem; Carman, Kursat Bora; Duman, Murat; Turel, Ozden; Yilmaz, Dilek; Alabaz, Derya; Belet, Nursen; Tanir, Gonul; Turgut, Mehmet; Celebi, Solmaz; Kuyucu, Necdet; Arisoy, Emin Sami; Durmaz, Gul; Kaya, Mucahit; Kara, Ates; Dinleyici, Ener Cagri

Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

土耳其SARS-CoV-2加强疫苗免疫原性的长期结果(混合COV-RAPEL TR研究):一项双盲、随机、对照、多中心II期临床研究

Ates, Ihsan; Batirel, Ayse; Aydin, Mehtap; Karadag, Fatma Yilmaz; Erden, Abdulsamet; Kucuksahin, Orhan; Armagan, Berkan; Guven, Serdar Can; Karakas, Ozlem; Gokdemir, Selim; Altunal, Lutfiye Nilsun; Buber, Aslihan Ayse; Gemcioglu, Emin; Zengin, Oguzhan; Inan, Osman; Sahiner, Enes Seyda; Korukluoglu, Gulay; Sezer, Zafer; Ozdarendeli, Aykut; Omma, Ahmet; Kara, Ates

Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials

灭活全病毒SARS-CoV-2疫苗TURKOVAC在健康成人中的安全性和免疫原性:随机、双盲、安慰剂对照的1期和2期试验的中期结果

Ozdarendeli, Aykut; Sezer, Zafer; Pavel, Shaikh Terkis Islam; Inal, Ahmet; Yetiskin, Hazel; Kaplan, Busra; Uygut, Muhammet Ali; Bayram, Adnan; Mazicioglu, Mumtaz; Unuvar, Gamze Kalin; Yuce, Zeynep Ture; Aydin, Gunsu; Aslan, Ahmet Furkan; Kaya, Refika Kamuran; Koc, Rabia Cakir; Ates, Ihsan; Kara, Ates

Reponse to Letter to The Editor: Regarding: Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines

回复编辑来信:关于:评估医护人员推荐疫苗的接种情况及其对SARS-CoV-2疫苗的接受度

Oygar, Pembe Derin; Kara, Ates

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.

在土耳其,非活性疫苗作为 COVID-19 加强剂的安全性和免疫原性:一项随机试验

Omma Ahmet, Batirel Ayse, Aydin Mehtap, Yilmaz Karadag Fatma, Erden Abdulsamet, Kucuksahin Orhan, Armagan Berkan, Güven Serdar Can, Karakas Ozlem, Gokdemir Selim, Altunal Lutfiye Nilsun, Buber Aslihan Ayse, Gemcioglu Emin, Zengin Oguzhan, Inan Osman, Sahiner Enes Seyda, Korukluoglu Gulay, Sezer Zafer, Ozdarendeli Aykut, Kara Ates, Ates Ihsan